Insulin Sensitivity: Clinical Trials

6 trials for Insulin Sensitivity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 unknown. 6 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 16Completed 5, Unknown 1

Follow Insulin Sensitivity: new trials by email Literature Review of Insulin Sensitivity trials Research Report on Insulin Sensitivity

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Novel Glucagon Receptor Antagonist REMD-477 on Glucose and Adipocyte Metabolism in T2DM
REMD-477, Placebo Subcutaneous injection - Type 2 Diabetes, Glucose Tolerance Impaired
Early Phase 1CompletedThe University of Texas Health Science Center at San Antonio42021-11-102024-08-09
Effects of Empagliflozin on Cardiac Microvasculature and Insulin Sensitivity in Subjects With Type 2 Diabetes
Empagliflozin 25 MG - Type2 Diabetes, Insulin Sensitivity
Early Phase 1UnknownUniversity of Virginia502020-02-012022-02-10
Low Dose Fat-Induced Insulin Resistance
Intralipid, 20% Intravenous Emulsion - Diabetes Mellitus, Type 2, Insulin Resistance
Early Phase 1CompletedUniversity of Pennsylvania92020-01-012026-04-15
Effect of Hyperglycemia on Microvascular Perfusion in Healthy Adults
Octreotide, Insulin, Dextrose 20% solution - Vascular Stiffness, Insulin Sensitivity
Early Phase 1CompletedUniversity of Virginia152019-02-042022-05-13
Effect of Physiologic Hyperglucogonemia on Adipocyte Metabolism
Glucagon Infusion, Saline - Insulin Sensitivity
Early Phase 1CompletedThe University of Texas Health Science Center at San Antonio102018-02-052024-10-21
The Effects of Sea Buckthorn and Strawberry on Postprandial Glycaemia, Insulinemia and Appetite
Meal sequence 1-2-3, Meal sequence 1-3-2, Meal sequence 2-3-1 - Insulin Sensitivity, Glucose Intolerance
Early Phase 1CompletedUniversity of Copenhagen182012-10-012015-04-09

Narrower conditions

Insulin Resistance (6)  ·  Diabetes Mellitus, Type 2 (2)  ·  Glucose Intolerance (2)

Broader conditions

Glucose Metabolism Disorders (6)  ·  Hyperinsulinism (6)  ·  Metabolic Diseases (6)  ·  Nutritional and Metabolic Diseases (6)  ·  Diabetes Mellitus (2)  ·  Endocrine System Diseases (2)  ·  Hyperglycemia (2)

Interventions

Glucagon (1)  ·  Glucose (1)  ·  Insulin (1)  ·  Octreotide (1)  ·  Saline Solution (1)  ·  Sodium Chloride (1)  ·  Solutions (1)  ·  empagliflozin (1)  ·  soybean oil, phospholipid emulsion (1)  ·  volagidemab (1)

Sponsors

The University of Texas Health Science Center at San Antonio (2)  ·  University of Virginia (2)  ·  University of Copenhagen (1)  ·  University of Pennsylvania (1)

Countries

United States (5)  ·  Denmark (1)

Top investigators

Ralph DeFronzo, MD (2)  ·  Eugene J Barrett, MD PhD (1)  ·  Lars O Dragsted, Ph.D. (1)  ·  Zoltan P Arany, MD, PhD (1)

Results publications

PMID 33481251, PMID 33908285

NIH funding

R01HL142250 (1), T32DK007646 (1)